InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
首席财务官已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Kuipers Peter J., 首席财务官. Officer active across 4 companies, notably OMNICELL, Inc. Cumulatively, 21 filings have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €78k. Activity tracked since 18 May 2021. The latest transaction was disclosed on 29 January 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Kuipers Peter J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报21 总计
156,856 股@ US$2.317.5% 占其流量Class A Common StockSEC:0001651691-26-000003:0
217,382 股@ US$3.6418.2% 占其流量Class A Common StockSEC:0001651691-25-000008:0
217,382 股@ US$2.8917.9% 占其流量Class A Common StockSEC:0001801170-25-000182:0
326,647 股0Class A Common StockSEC:0001801170-25-000145:0
825,989 股@ US$3.45100.0% 占其流量Class A Common StockSEC:0001801170-25-000109:0
66,860 股0Common StockSEC:0001209191-23-054372:0
2,292 股@ US$72.3215.0% 占其流量Common StockSEC:0001415889-23-009923:0
4,196 股@ US$48.4418.8% 占其流量Common StockSEC:0001415889-22-012730:0
4,040 股@ US$44.2517.7% 占其流量Common StockSEC:0001415889-22-009180:0
11,000 股@ US$44.2548.4% 占其流量Common StockSEC:0001415889-22-008995:0
4,193 股@ US$113.110.023% mcap74.5% 占其流量Common StockSEC:0001415889-22-006770:0
19,040 股0Common StockSEC:0001179110-22-002274:0
9,988 股0Common StockSEC:0001179110-22-001402:0
3,740 股0Common StockSEC:0001179110-21-011071:0
5,640 股0Common StockSEC:0001179110-21-010704:0
5,640 股0Common StockSEC:0001179110-21-008008:0
15,587 股0Common StockSEC:0001179110-21-007834:0
3,132 股0Common StockSEC:0001179110-21-006764:0
707 股@ US$134.4914.6% 占其流量Common StockSEC:0001179110-21-005513:0
2,170 股Common StockSEC:0001179110-16-018773:0
7,220 股Common StockSEC:0001179110-16-018773:1
21 条申报中的 21 条
About Kuipers Peter J.
Kuipers Peter J. is Directeur Financier. He has 21 filings in total, and, across the sampled recent filings covered here, sales amount to EUR 77,785 with no purchases, over the period from 2016-02-08 to 2026-02-02. The most frequent transaction nature is Retenue fiscale, and the recent filings concern Clover Health Investments, CORP. /de and OMNICELL, with individual amounts of EUR 2,502,060.169307661, EUR 678,743.9010307911, EUR 543,881.0224017561, EUR 489,714.3434202904, EUR 453,577.8100783052 and EUR 302,508.2182440785.
